Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 22, 2018 09:11 ET | Source: GeneTx Biotherapeutics

New biotech launched for antisense program targeting Angelman syndrome

Downers Grove, Ill., Feb. 22, 2018 (GLOBE NEWSWIRE) -- FAST (Foundation for Angelman Syndrome Therapeutics) announced today the launch of GeneTx Biotherapeutics LLC (GeneTx), a subsidiary of FAST,...